Liensinine and Nuciferine, Bioactive Components of Nelumbo nucifera, Inhibit the Growth of Breast Cancer Cells and Breast Cancer-Associated Bone Loss.

about

Liensinine and Nuciferine, Bioactive Components of Nelumbo nucifera, Inhibit the Growth of Breast Cancer Cells and Breast Cancer-Associated Bone Loss.

Item

http://www.wikidata.org/entity/Q48247265

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Liensinine and Nuciferine, Bio ...... t Cancer-Associated Bone Loss.

@en

Liensinine and Nuciferine, Bio ...... t Cancer-Associated Bone Loss.

@nl

type

Item

label

Liensinine and Nuciferine, Bio ...... t Cancer-Associated Bone Loss.

@en

Liensinine and Nuciferine, Bio ...... t Cancer-Associated Bone Loss.

@nl

prefLabel

Liensinine and Nuciferine, Bio ...... t Cancer-Associated Bone Loss.

@en

Liensinine and Nuciferine, Bio ...... t Cancer-Associated Bone Loss.

@nl

P1476

Liensinine and Nuciferine, Bio ...... st Cancer-Associated Bone Loss

@en

P2093

Eun Ji Kang

http://www.w3.org/2001/XMLSchema#string

Ki Rim Kim

http://www.w3.org/2001/XMLSchema#string

Kwang-Kyun Park

http://www.w3.org/2001/XMLSchema#string

Seung Hwa Son

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

RANKL-RANK signaling in osteoclastogenesis and bone disease

Identification and comparison of anti-inflammatory ingredients from different organs of Lotus nelumbo by UPLC/Q-TOF and PCA coupled with a NF-κB reporter gene assay

15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss

Metastasis to bone: causes, consequences and therapeutic opportunities

Effect of bisphosphonates on pain and quality of life in patients with bone metastases.

Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss

The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.

Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities.

Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation.

P304

1583185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/1583185

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Won-Yoon Chung

Sun Kyoung Lee

P577

2017-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29333179

http://www.w3.org/2001/XMLSchema#string

P932

5733186

http://www.w3.org/2001/XMLSchema#string